doi:10.3748/wjg.14.4209 © 2008 The WJG Press. All rights reserved. Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration of chitosan nanoparticles containing human insulin gen
Insulin gene therapy in clinical medicine is currently hampered by the inability to regulate insulin...
Diabetes prevalence is steadily increasing and both type 1 and type 2 contribute to this “diabetes e...
Abstract Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals th...
Poorly controlled diabetes mellitus can result in serious complications. Gene therapy is increasingl...
The purpose of this study was to determine whether the treatment with recombinant plasmid consisted ...
10.1016/j.ijpharm.2004.12.025International Journal of Pharmaceutics2931-2271-280IJPH
[[abstract]]Current insulin therapy via subcutaneous administration can lead to occasional hypoglyce...
Daily injections for basal insulin therapy are far from ideal resulting in hypo/hyperglycemic episod...
[[abstract]]This work examined the feasibility of preparing a pH-responsive nanoparticle (NP) system...
AbstractThis work examined the feasibility of preparing a pH-responsive nanoparticle (NP) system com...
Diabetes mellitus is a chronic metabolic disorder. To improve patient compliance and alleviate the u...
[[abstract]]Novel nanoparticles (NPs) coated with chitosan which allow insulin to be administered or...
Abstract Purpose To evaluate the pharmacological activity of insulin-loaded alginate/chitosan nanop...
The pharmacological activity of insulin-loaded dextran sulfate/chitosan nanoparticles was evaluated ...
The smart self-regulated drug delivery systems for insulin administration are desirable to achieve g...
Insulin gene therapy in clinical medicine is currently hampered by the inability to regulate insulin...
Diabetes prevalence is steadily increasing and both type 1 and type 2 contribute to this “diabetes e...
Abstract Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals th...
Poorly controlled diabetes mellitus can result in serious complications. Gene therapy is increasingl...
The purpose of this study was to determine whether the treatment with recombinant plasmid consisted ...
10.1016/j.ijpharm.2004.12.025International Journal of Pharmaceutics2931-2271-280IJPH
[[abstract]]Current insulin therapy via subcutaneous administration can lead to occasional hypoglyce...
Daily injections for basal insulin therapy are far from ideal resulting in hypo/hyperglycemic episod...
[[abstract]]This work examined the feasibility of preparing a pH-responsive nanoparticle (NP) system...
AbstractThis work examined the feasibility of preparing a pH-responsive nanoparticle (NP) system com...
Diabetes mellitus is a chronic metabolic disorder. To improve patient compliance and alleviate the u...
[[abstract]]Novel nanoparticles (NPs) coated with chitosan which allow insulin to be administered or...
Abstract Purpose To evaluate the pharmacological activity of insulin-loaded alginate/chitosan nanop...
The pharmacological activity of insulin-loaded dextran sulfate/chitosan nanoparticles was evaluated ...
The smart self-regulated drug delivery systems for insulin administration are desirable to achieve g...
Insulin gene therapy in clinical medicine is currently hampered by the inability to regulate insulin...
Diabetes prevalence is steadily increasing and both type 1 and type 2 contribute to this “diabetes e...
Abstract Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals th...
DOI
Add to ORKG